Results 61 to 70 of about 88,642,428 (226)

THE FORMATION OF 6-MERCAPTOPURINE RIBOSIDE PHOSPHATE IN ASCITES TUMOR CELLS

open access: yes, 1959
A nucleotide metabolite of 6-mercaptopurine has been isolated from Erhlich ascites carcinoma cells exposed to this compound under in vivo and in vitro conditions.
A. R. P. Paterson
core   +1 more source

CTAB functionalized multiwalled carbon nanotube composite modified electrode for the determination of 6-mercaptopurine

open access: yesSensing and Bio-Sensing Research, 2017
In this work the electrochemical behavior of 6-mercaptopurine (6-MP) on MWCNT-CTAB modified glassy carbon electrode (GCE) is reported in a phosphate buffer solution, pH 3.0. Cyclic voltammetric studies indicated that the oxidation process is irreversible
Jayant I. Gowda   +2 more
doaj   +1 more source

6-Mercaptopurine teratogenicity [PDF]

open access: yesPostgraduate Medical Journal, 2002
We read with interest the review article on inflammatory bowel disease (IBD) in pregnancy.1 The author mentions that there has never been any demonstration of teratogenicity of 6-mercaptopurine (or azathioprine) in humans. We would like to report a case, which we encountered, of an infant with multiple congenital abnormalities whose mother received 6 ...
D H Tegay, R Tepper, J P Willner
openaire   +1 more source

Association of attention‐deficit/hyperactivity disorder and autism with inflammatory bowel disease activity

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives To estimate the effect of attention deficit hyperactivity disorder (ADHD) and autism on the disease activity of inflammatory bowel disease (IBD) in pediatric and young patients. Methods Patients diagnosed with IBD between the ages of 6 and 24 years were identified in Danish nationwide registries 1996–2022.
Sabine Jansson   +7 more
wiley   +1 more source

RESISTANCE TO 6-MERCAPTOPURINE: III. DELETION OF A 5′-NUCLEOTIDASE IN A 6-MERCAPTOPURINE-RESISTANT SUBLINE OF THE EHRLICH ASCITES CARCINOMA

open access: yes, 1963
Nuclei prepared from cells of a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma differed from nuclei isolated from the parent line of cells in being markedly deficient in an enzymatic activity, 5′-nucleotidase.The nucleotidase ...
A. Hori, A. R. P. Paterson
core   +1 more source

Use of Allopurinol with Low-Dose 6-Mercaptopurine in Inflammatory Bowel Disease to Achieve Optimal Active Metabolite Levels: A Review of Four Cases and the Literature

open access: yesCanadian Journal of Gastroenterology, 2008
BACKGROUND: At least one-third of patients with inflammatory bowel disease do not respond or are intolerant to therapy with 6-mercaptopurine (6-MP). A subgroup fails to attain optimal levels of 6-thioguanine nucleotide (6-TGN) and instead shunts to 6 ...
Todd N Witte, Allen L Ginsberg
doaj   +1 more source

Phytocorrection of Gastrointestinal Tract Structural Changes Caused by the Use of 6-Mercaptopurine

open access: yesАнтибиотики и Химиотерапия, 2020
It was shown that the course use of Ventrofit, a complex plant remedy, normalized the structural and functional integrity of the stomach and thin intestine mucous membranes damaged by the use of 6-mercaptopurine.
YA. G. Razuvaeva   +4 more
doaj  

Interaction of 6 mercaptopurine with calf thymus DNA--deciphering the binding mode and photoinduced DNA damage. [PDF]

open access: yesPLoS ONE, 2014
DNA is one of the major intracellular targets for a wide range of anticancer and antibiotic drugs. Elucidating the binding between small molecules and DNA provides great help in understanding drug-DNA interactions and in designing of new and promising ...
Sayeed Ur Rehman   +5 more
doaj   +1 more source

Outcomes of adalimumab biosimilar nonmedical switches in children and young adults with inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objectives Adalimumab biosimilars are as safe and effective compared to the originator. Adult patients with inflammatory bowel disease (IBD) who switched to a biosimilar have comparable outcomes, but pediatric data are limited. This study evaluates clinical outcomes of children and young adults with IBD following a nonmedical, insurance‐driven
Daniel Himelstein   +5 more
wiley   +1 more source

Improving the Solubility of 6‑Mercaptopurine via Cocrystals and Salts

open access: yes, 2016
An antitumor drug, 6-mercaptopurine monohydrate, has a low oral bioavailability (about 16%) due to its poor aqueous solubility. To improve its solubility, two cocrystals of 6-mercaptopurine with 4-hydroxybenzoic acid (1) and 2,4-dihydroxybenzoic acid (2),
Tong-Bu Lu (1516030)   +3 more
core   +4 more sources

Home - About - Disclaimer - Privacy